Overview

A Two-Part Study to Determine: Best Medication Formulation and Food Effect

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This is a two-part study. Part 1 is designed to find the best modified release formulation of GW423753; Part 2 is designed to use the selected formulation(s) from Part 1 to find out if food affects the way the medication is processed by the body.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Solabegron